Nomura Adjusts Sinopharm's Price Target to HK$30.33 From HK$32.39, Keeps at Buy
Nomura Adjusts Sinopharm Group's Price Target to HK$32.39 Form HK$33.31, Keeps at Buy
UBS Adjusts Sinopharm Group's Price Target to HK$26 From HK$28, Keeps at Buy
No Data